AU5547594A - Microcrystalline cellulose as an immune adjuvant - Google Patents
Microcrystalline cellulose as an immune adjuvantInfo
- Publication number
- AU5547594A AU5547594A AU55475/94A AU5547594A AU5547594A AU 5547594 A AU5547594 A AU 5547594A AU 55475/94 A AU55475/94 A AU 55475/94A AU 5547594 A AU5547594 A AU 5547594A AU 5547594 A AU5547594 A AU 5547594A
- Authority
- AU
- Australia
- Prior art keywords
- microcrystalline cellulose
- immune adjuvant
- adjuvant
- immune
- microcrystalline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US971161 | 1978-12-20 | ||
US97116192A | 1992-11-03 | 1992-11-03 | |
PCT/US1993/010575 WO1994009819A1 (en) | 1992-11-03 | 1993-11-03 | Microcrystalline cellulose as an immune adjuvant |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5547594A true AU5547594A (en) | 1994-05-24 |
Family
ID=25518001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU55475/94A Abandoned AU5547594A (en) | 1992-11-03 | 1993-11-03 | Microcrystalline cellulose as an immune adjuvant |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5547594A (en) |
WO (1) | WO1994009819A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1285753A (en) * | 1997-12-02 | 2001-02-28 | 鲍德杰克特疫苗公司 | Transdermal delivery of particulate vaccine compositions |
US6881723B1 (en) | 1998-11-05 | 2005-04-19 | Powderject Vaccines, Inc. | Nucleic acid constructs |
CA2361555A1 (en) | 1999-02-03 | 2000-08-10 | Powderject Research Limited | Hydrogel particle formulations |
US7022320B1 (en) | 1999-02-09 | 2006-04-04 | Powderject Vaccines, Inc. | Mycobacterium tuberculosis immunization |
US7196066B1 (en) | 1999-11-03 | 2007-03-27 | Powderject Vaccines, Inc. | DNA-vaccines based on constructs derived from the genomes of human and animal pathogens |
KR102136036B1 (en) * | 2010-04-15 | 2020-07-20 | 신 니뽄 바이오메디칼 라보라토리즈, 엘티디. | Methods and compositions for intranasal delivery |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4874614A (en) * | 1985-03-25 | 1989-10-17 | Abbott Laboratories | Pharmaceutical tableting method |
-
1993
- 1993-11-03 WO PCT/US1993/010575 patent/WO1994009819A1/en active Application Filing
- 1993-11-03 AU AU55475/94A patent/AU5547594A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1994009819A1 (en) | 1994-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU639126B2 (en) | Oxorapamycin | |
AU8097291A (en) | Surround processor | |
AU1508692A (en) | Turbine | |
AU7578791A (en) | Hemi-wedge valve | |
AU8405691A (en) | Novel tetrahydrobenzazole derivative | |
AU7846991A (en) | Aminobenzodiazepines | |
AU2482492A (en) | Headset | |
AU1050492A (en) | An optical concentrator | |
AU5238690A (en) | Solar still assembly | |
AU8420191A (en) | Headwear | |
AU7956191A (en) | Transportsystem | |
AUPM543894A0 (en) | An adjuvant | |
AU2390792A (en) | Thienopyrimidin-4-one derivative | |
AU7726391A (en) | Slitterscorer | |
AU5547594A (en) | Microcrystalline cellulose as an immune adjuvant | |
AU639075B2 (en) | Governor | |
AU7123791A (en) | Interference suppression system | |
AU641516B2 (en) | Back-rest | |
AU2449592A (en) | 4-acylaminoimidazole derivative | |
AU7976491A (en) | Special effects controller | |
AU8516291A (en) | Instant photograph-postcard | |
AU603759B3 (en) | Internal pipecutter | |
AU7922191A (en) | 2-acylamino-7-chlorobenzothiazoles | |
RU1802204C (en) | Windmill | |
AU3174393A (en) | Knock down furniture |